Affirm Beats Fiscal Q1 2027 Estimates as Revenue Rises 35% to $1.26B

Affirm (AFRM) beat estimates for the fiscal first quarter of 2027 on both revenue and adjusted EPS. Revenue was $1.26 billion, up 35% from a year earlier, above the $1.21 billion estimate, and adjusted EPS was $0.47, up 104% from a year earlier, above the $0.38 estimate.

Shares fell 0.4% in after-hours trading as of 4:06 p.m. ET, to $69.36 from a $69.66 close.

Fiscal Q1 2027 scorecard

By our calculation, revenue was $49.4 million above the estimate and adjusted EPS was $0.09 above it. The QoQ column compares with the previous quarter's revenue of $1.17 billion and adjusted EPS of $4.62. The YoY column compares with $933.3 million and $0.23 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 7 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $933.3 million, $1.12 billion, $1.04 billion, $1.17 billion and $1.26 billion.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $0.55 and revenue of $1.43 billion next quarter, based on 6 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 35% increase to $1.26 billion.
• Estimate record. Whether Affirm extends a record of beating EPS estimates in 8 of its last 8 reports.
• Related coverage. See our reports on Solventum, Nutex Health, Texas Roadhouse and Globus Medical.

Sources: Results are from Affirm's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Affirm's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.